{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:48:08Z","timestamp":1790182088319,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000555","name":"British Microcirculation Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000779","name":"University of London","doi-asserted-by":"publisher","award":["PHD\/0197\/2557"],"award-info":[{"award-number":["PHD\/0197\/2557"]}],"id":[{"id":"10.13039\/501100000779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jamda.2019.11.022","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T23:41:18Z","timestamp":1578354078000},"page":"1058-1064.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Safety and Effectiveness of Direct Oral Anticoagulants vs Warfarin in People With Atrial Fibrillation and Dementia"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-3875","authenticated-orcid":false,"given":"Laura","family":"Fanning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallis C.Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pajaree","family":"Mongkhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Simon","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Ilom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8554-7432","authenticated-orcid":false,"given":"P\u0113teris","family":"D\u0101rzi\u0146\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui Kai","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8840-7267","authenticated-orcid":false,"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2019.11.022_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/jce.13261","article-title":"Atrial fibrillation, cognition and dementia: A review","volume":"28","author":"Aldrugh","year":"2017","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jamda.2019.11.022_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/europace\/eux031","article-title":"Does atrial fibrillation cause cognitive decline and dementia?","volume":"20","author":"Dietzel","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jamda.2019.11.022_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1532-5415.1996.tb00908.x","article-title":"Cognitive impairment and risk of stroke in the older population","volume":"44","author":"Ferrucci","year":"1996","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2019.11.022_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjopharm.2009.06.002","article-title":"Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and\/or early-stage dementia: A single-center, retrospective, observational study","volume":"7","author":"Jacobs","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jamda.2019.11.022_bib5","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jamda.2019.11.022_bib6","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2019.11.022_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: A systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.jamda.2019.11.022_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/1755-5922.12129","article-title":"Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation","volume":"33","author":"Steinberg","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jamda.2019.11.022_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-180219","article-title":"Prevalence, safety, and effectiveness of oral anticoagulant use in people with and without dementia or cognitive impairment: A systematic review and meta-analysis","volume":"65","author":"Fanning","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2019.11.022_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3233\/JAD-170575","article-title":"Treatment of atrial fibrillation in patients with dementia: A cohort study from the Swedish Dementia Registry","volume":"61","author":"Subic","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2019.11.022_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3233\/JAD-140666","article-title":"Association between stroke and Alzheimer's disease: Systematic review and meta-analysis","volume":"43","author":"Zhou","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2019.11.022_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archneur.1995.00540310076019","article-title":"Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension","volume":"52","author":"Olichney","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2019.11.022_bib13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.jamda.2019.11.022_bib14","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.jamda.2019.11.022_bib15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.jamda.2019.11.022_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.jamda.2019.11.022_bib17","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00228-017-2297-0","article-title":"The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillation","volume":"73","author":"Fanning","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2019.11.022_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2018.09.017","article-title":"Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial","volume":"208","author":"Alexander","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jamda.2019.11.022_bib19","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.0000000000000831","article-title":"Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"83","author":"Culebras","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2019.11.022_bib20","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: Demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"10.1016\/j.jamda.2019.11.022_bib21","author":"National Health Service (NHS)"},{"key":"10.1016\/j.jamda.2019.11.022_bib23","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1212\/WNL.0000000000004694","article-title":"Low-dose aspirin and risk of intracranial bleeds: An observational study in UK general practice","volume":"89","author":"Cea Soriano","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2019.11.022_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population","volume":"81","author":"Garcia-Rodriguez","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2019.11.022_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2019.11.022_bib26","doi-asserted-by":"crossref","first-page":"e1002728","DOI":"10.1371\/journal.pmed.1002728","article-title":"Trazodone use and risk of dementia: A population-based cohort study","volume":"16","author":"Brauer","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jamda.2019.11.022_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.3334","article-title":"The incident user design in comparative effectiveness research","volume":"22","author":"Johnson","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2019.11.022_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-121819","article-title":"Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK","volume":"35","author":"Imfeld","year":"2013","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2019.11.022_bib29","doi-asserted-by":"crossref","first-page":"k1315","DOI":"10.1136\/bmj.k1315","article-title":"Anticholinergic drugs and risk of dementia: Case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.11.022_bib30","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2019.11.022_bib31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/CIRCOUTCOMES.113.000192","article-title":"Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin","volume":"6","author":"Zalesak","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jamda.2019.11.022_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","article-title":"Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation","volume":"131","author":"Graham","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2019.11.022_bib33","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/jth.13780","article-title":"Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin","volume":"15","author":"Lau","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jamda.2019.11.022_bib34","doi-asserted-by":"crossref","first-page":"k2505","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: Cohort study in primary care","volume":"362","author":"Vinogradova","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.11.022_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pds.1919","article-title":"Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN)","volume":"19","author":"Ruigomez","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2019.11.022_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pds.3391","article-title":"Incidence of hemorrhagic stroke in the general population: Validation of data from The Health Improvement Network","volume":"22","author":"Gaist","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2019.11.022_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.jamda.2019.11.022_bib38","doi-asserted-by":"crossref","first-page":"e004958","DOI":"10.1136\/bmjopen-2014-004958","article-title":"Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: A cross-sectional study","volume":"4","author":"Marston","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2019.11.022_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jamda.2019.11.022_bib40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jamda.2019.11.022_bib41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/joim.12197","article-title":"Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs","volume":"275","author":"Sturmer","year":"2014","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jamda.2019.11.022_bib42","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jamda.2019.11.022_bib43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: Dealing with observations in the tails of the propensity score distribution\u2014a simulation study","volume":"172","author":"Sturmer","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2019.11.022_bib44","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2013.280500","article-title":"Association between oral fluoroquinolone use and retinal detachment","volume":"310","author":"Pasternak","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2019.11.022_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2017.1363","article-title":"Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation","volume":"317","author":"Lau","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2019.11.022_bib47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"27","author":"Brieger","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jamda.2019.11.022_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/gerona\/glr066","article-title":"Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults","volume":"67","author":"Hilmer","year":"2012","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2019.11.022_bib49","doi-asserted-by":"crossref","first-page":"i3189","DOI":"10.1136\/bmj.i3189","article-title":"Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: Propensity weighted nationwide cohort study","volume":"353","author":"Larsen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.11.022_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: A systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jamda.2019.11.022_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamacardio.2016.0199","article-title":"Outcomes in a warfarin-treated population with atrial fibrillation","volume":"1","author":"Bj\u00f6rck","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jamda.2019.11.022_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.wad.0000165511.52746.1f","article-title":"Association between dementia and infectious disease: Evidence from a case-control study","volume":"19","author":"Dunn","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2019.11.022_bib53","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S2468-2667(17)30031-2","article-title":"Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: A longitudinal retrospective cohort study","volume":"2","author":"Donegan","year":"2017","journal-title":"Lancet Public Health"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101930831X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101930831X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:21:10Z","timestamp":1761506470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152586101930831X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S152586101930831X"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2019.11.022","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Effectiveness of Direct Oral Anticoagulants vs Warfarin in People With Atrial Fibrillation and Dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2019.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}